Author:
Kornblith Paul L,Rosa Louis,Bona James D,Edwards John A,Matuzic Nancy,Hirschfeld Alan,Hawkins Calvin
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference24 articles.
1. Schilsky RL, Kelley JA, Ihde DC, Howser DM, Cordes RS, Young RC: Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans. Cancer Res 421:1582–1586, 1982.
2. Khan AH, Driscoll JS: Potential central nervous system antitumor agents. Aziridinylbenzoquinones I. J Med Chem 19:313–317, 1976.
3. Chou F, Khan AH, Driscoll JS: Potential central nervous system antitumor agents. Aziridinylbenzoquinones II. J Med Chem 19:1302–1308, 1976.
4. Akhtar MH, Begleiter A, Johnson D, Lown JW, McLaughlin L, Sim SK: Studies related to antitumor antibiotics. Part IV. Correlation of covalent cross-linking of DNA by bifunctional aziridinylbenzoquinones with their antineoplastic activities. Can J Chem 53:2891–2905, 1975.
5. Oberc-Greenwood MA, Smith BH et al.: Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone. JNCI 71:723–733, 1983.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献